Skip to main content Accessibility help
×
×
Home

Vitamin D in schizophrenia and depression: a clinical review

  • John Lally (a1) and Fiona Gaughran (a2)
Summary

Evidence from preclinical and clinical studies supports a role for vitamin D deficiency in many mental disorders. In this review, we discuss the role of vitamin D in the aetiology and treatment of schizophrenia and depression and their physical health comorbidities. Although observational studies support a potential association between vitamin D and schizophrenia and depression, sufficient high-quality evidence from clinical trials does not yet exist to establish a place for vitamin D supplementation in optimising clinical response or promoting physical health. Completed randomised controlled trials are needed to provide insights into the efficacy and safety of vitamin D in the management of mental disorders.

LEARNING OBJECTIVES

After reading this article you will be able to:

  • outline the epidemiology of vitamin D deficiency in schizophrenia
  • describe the associations of vitamin D with schizophrenia and depression
  • know how to assess, and consider treatment for, vitamin D deficiency.

DECLARATION OF INTEREST

F.G. has received support or honoraria for CME, advisory work and lectures from Bristol-Myers Squibb, Janssen, Lundbeck, Otsuka, Roche and Sunovion, and has a family member with professional links to Lilly and GSK, including shares. She is in part funded by the National Institute for Health Research's (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London and the South London Collaboration for Leadership in Applied Health Research & Care Funding scheme, and by the Maudsley Charity. The views expressed in this article are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care.

Copyright
Corresponding author
Correspondence Dr John Lally, PO63, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park, London SE5 8AF, UK. Email: john.lally@kcl.ac.uk
Footnotes
Hide All

See commentary, this issue.

Footnotes
References
Hide All
Adamson, J, Lally, J, Gaughran, F, et al. (2017) Correlates of vitamin D in psychotic disorders: a comprehensive systematic review. Psychiatry Research, 249: 7885.
Alavi, NM, Khademalhoseini, S, Vakili, Z, et al. (2018) Effect of vitamin D supplementation on depression in elderly patients: a randomized clinical trial. Clinical Nutrition, Sep 19: doi 10.1016/j.clnu.2018.09.011 [Epub ahead of print].
Albayrak, Y, Ünsal, C, Beyazyüz, M, et al. (2013) Reduced total antioxidant level and increased oxidative stress in patients with deficit schizophrenia: a preliminary study. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 45: 144–9.
Anglin, RE, Samaan, Z, Walter, SD, et al. (2013) Vitamin D deficiency and depression in adults: systematic review and meta-analysis. British Journal of Psychiatry, 202: 100–7.
Aspray, TJ, Bowring, C, Fraser, W, et al. (2014) National Osteoporosis Society vitamin D guideline summary. Age and Ageing, 43: 592–5.
Bergemann, N, Parzer, P, Mundt, C, et al. (2008) High bone turnover but normal bone mineral density in women suffering from schizophrenia. Psychological Medicine, 38: 1195–201.
Chan, R, Chan, D, Woo, J, et al. (2011) Association between serum 25-hydroxyvitamin D and psychological health in older Chinese men in a cohort study. Journal of Affective Disorders, 130: 251–9.
Chen, N, Wan, Z, Han, SF, et al. (2014) Effect of vitamin D supplementation on the level of circulating high-sensitivity C-reactive protein: a meta-analysis of randomized controlled trials. Nutrients, 6: 2206–16.
Chowdhury, R, Kunutsor, S, Vitezova, A, et al. (2014) Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ, 348: g1903.
Crews, M, Lally, J, Gardner-Sood, P, et al. (2013) Vitamin D deficiency in first episode psychosis: a case–control study. Schizophrenia Research, 150: 533–7.
Davies, G, Welham, J, Chant, D, et al. (2003) A systematic review and meta-analysis of Northern Hemisphere season of birth studies in schizophrenia. Schizophrenia Bulletin, 29: 587–93.
Dawson-Hughes, B, Mithal, A, Bonjour, J-P, et al. (2010) IOF position statement: vitamin D recommendations for older adults. Osteoporosis International, 21: 1151–4.
Dean, AJ, Bellgrove, MA, Hall, T, et al. (2011) Effects of vitamin D supplementation on cognitive and emotional functioning in young adults – a randomised controlled trial. PLoS One, 6: e25966.
Dumville, JC, Miles, JN, Porthouse, J, et al. (2006) Can vitamin D supplementation prevent winter-time blues? A randomised trial among older women. Journal of Nutrition, Health and Aging, 10: 151–3.
Ebeling, PR (2014) Vitamin D and bone health: epidemiologic studies. BoneKEy Reports, 3: 511.
Egerton, A, Brugger, S, Raffin, M, et al. (2012) Anterior cingulate glutamate levels related to clinical status following treatment in first-episode schizophrenia. Neuropsychopharmacology, 37: 2515–21.
Eyles, DW, Burne, TH, McGrath, JJ (2013) Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease. Frontiers in Neuroendocrinology, 34: 4764.
Eyles, DW, Trzaskowski, M, Vinkhuyzen, AAE, et al. (2018) The association between neonatal vitamin D status and risk of schizophrenia. Scientific Reports, 8: 17692.
Ford, L, Graham, V, Wall, A, et al. (2006) Vitamin D concentrations in an UK inner-city multicultural outpatient population. Annals of Clinical Biochemistry, 43: 468–73.
Garcion, E, Thanh, XD, Bled, F, et al. (1996) 1,25-Dihydroxyvitamin D3 regulates gamma 1 transpeptidase activity in rat brain. Neuroscience Letters, 216: 183–6.
Garcion, E, Wion-Barbot, N, Montero-Menei, CN, et al. (2002) New clues about vitamin D functions in the nervous system. Trends in Endocrinology and Metabolism, 13: 100–5.
Gloth, FM III, Alam, W, Hollis, B (1999) Vitamin D vs broad spectrum phototherapy in the treatment of seasonal affective disorder. Journal of Nutrition, Health and Aging, 3: 57.
Gomez, L, Stubbs, B, Shirazi, A, et al. (2016) Lower bone mineral density at the hip and lumbar spine in people with psychosis versus controls: a comprehensive review and skeletal site-specific meta-analysis. Current Osteoporosis Reports, 14: 249–59.
Graham, KA, Keefe, RS, Lieberman, JA, et al. (2015) Relationship of low vitamin D status with positive, negative and cognitive symptom domains in people with first-episode schizophrenia. Early Intervention in Psychiatry, 9: 397405.
Hallahan, B, Lyons, D, Doyle, P (2008) Bone mineral density and general health of long-term residential psychiatric inpatients. Irish Journal of Psychological Medicine, 25: 95–9.
Harms, LR, Eyles, DW, McGrath, JJ, et al. (2008) Developmental vitamin D deficiency alters adult behaviour in 129/SvJ and C57BL/6J mice. Behavioural Brain Research, 187: 343–50.
Hilger, J, Friedel, A, Herr, R, et al. (2014) A systematic review of vitamin D status in populations worldwide. British Journal of Nutrition, 111: 2345.
Holick, MF (1995) Environmental factors that influence the cutaneous production of vitamin D. American Journal of Clinical Nutrition, 61: 638S–45S.
Holick, MF, Chen, TC, Lu, Z, et al. (2007) Vitamin D and skin physiology: a D-lightful story. Journal of Bone and Mineral Research, 22(suppl 2): V28–33.
Holick, M, Chen, T (2008) Vitamin D deficiency: a worldwide problem with health consequences. American Journal of Clinical Nutrition, 87: 1080S–6S.
Holick, MF, Binkley, NC, Bischoff-Ferrari, HA, et al. (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism, 96: 1911–30.
Holick, MF (2013) Vitamin D: physiology, dietary sources, and requirements. In Encyclopedia of Human Nutrition (3rd edn) (eds Caballero, B, Allen, L, Prentice, A): 323–32. Academic Press.
Hypponen, E, Power, C (2007) Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors. American Journal of Clinical Nutrition, 85: 860–8.
Jiang, X, O'Reilly, PF, Aschard, H, et al. (2018) Genome-wide association study in 79,366 European-ancestry individuals informs the genetic architecture of 25-hydroxyvitamin D levels. Nature Communications, 9: 260.
Jorde, R, Sneve, M, Figenschau, Y, et al. (2008) Effects of vitamin D supplementation on symptoms of depression in overweight and obese subjects: randomized double blind trial. Journal of Internal Medicine, 264: 599609.
Jovanova, O, Aarts, N, Noordam, R, et al. (2017) Vitamin D serum levels are cross-sectionally but not prospectively associated with late-life depression. Acta Psychiatrica Scandinavica, 135: 185–94.
Khoraminya, N, Tehrani-Doost, M, Jazayeri, S, et al. (2013) Therapeutic effects of vitamin D as adjunctive therapy to fluoxetine in patients with major depressive disorder. Australian and New Zealand Journal of Psychiatry, 47: 271–5.
Kjærgaard, M, Waterloo, K, Wang, CE, et al. (2012) Effect of vitamin D supplement on depression scores in people with low levels of serum 25-hydroxyvitamin D: nested case–control study and randomised clinical trial. British Journal of Psychiatry, 201: 360–8.
Krivoy, A, Onn, R, Vilner, Y, et al. (2017) Vitamin D supplementation in chronic schizophrenia patients treated with clozapine: a randomized, double-blind, placebo-controlled clinical trial. EBioMedicine, 26: 138–45.
Lally, J, Gardner-Sood, P, Firdosi, M, et al. (2016) Clinical correlates of vitamin D deficiency in established psychosis. BMC Psychiatry, 16: 19.
Lally, J, Ajnakina, O, Stubbs, B, et al. (2017) Remission and recovery from first-episode psychosis in adults: systematic review and meta-analysis of long-term outcome studies. British Journal of Psychiatry, 211: 350–8.
Lally, J, Ajnakina, O, Singh, N, et al. (2018) Vitamin D and clinical symptoms in First Episode Psychosis (FEP): a prospective cohort study. Schizophrenia Research, Aug 25: doi 10.1016/j.schres.2018.08.011 [Epub ahead of print].
Li, G, Mbuagbaw, L, Samaan, Z, et al. (2014) Efficacy of vitamin D supplementation in depression in adults: a systematic review. Journal of Clinical Endocrinology and Metabolism, 99: 757–67.
Lips, P (2007) Relative value of 25(OH)D and 1,25(OH)2D measurements. Journal of Bone and Mineral Research, 22: 1668–71.
Manson, JE, Cook, NR, Lee, IM, et al. (2019) Vitamin D supplements and prevention of cancer and cardiovascular disease. New England Journal of Medicine, 380: 3344.
Marsh, WK, Penny, JL, Rothschild, AJ (2017) Vitamin D supplementation in bipolar depression: a double blind placebo controlled trial. Journal of Psychiatric Research, 95: 4853.
May, HT, Bair, TL, Lappe, DL, et al. (2010) Association of vitamin D levels with incident depression among a general cardiovascular population. American Heart Journal, 159: 1037–43.
McGrath, J (1999) Hypothesis: is low prenatal vitamin D a risk-modifying factor for schizophrenia? Schizophrenia Research, 40: 173–7.
McGrath, J, Saari, K, Hakko, H, et al. (2004) Vitamin D supplementation during the first year of life and risk of schizophrenia: a Finnish birth cohort study. Schizophrenia Research, 67: 237–45.
McGrath, JJ, Eyles, DW, Pedersen, CB, et al. (2010) Neonatal vitamin D status and risk of schizophrenia: a population-based case-control study. Archives of General Psychiatry, 67: 889–94.
Milaneschi, Y, Shardell, M, Corsi, AM, et al. (2010) Serum 25-hydroxyvitamin D and depressive symptoms in older women and men. Journal of Clinical Endocrinology and Metabolism, 95: 3225–33.
Mitra, S, Natarajan, R, Ziedonis, D, et al. (2017) Antioxidant and anti-inflammatory nutrient status, supplementation, and mechanisms in patients with schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 78: 111.
Mozaffari-Khosravi, H, Nabizade, L, Yassini-Ardakani, SM, et al. (2013) The effect of 2 different single injections of high dose of vitamin D on improving the depression in depressed patients with vitamin D deficiency: a randomized clinical trial. Journal of Clinical Psychopharmacology, 33: 378–85.
Nerhus, M, Berg, AO, Kvitland, LR, et al. (2016) Low vitamin D is associated with negative and depressive symptoms in psychotic disorders. Schizophrenia Research, 178: 44–9.
Nowson, CA, McGrath, JJ, Ebeling, PR, et al. (2012) Vitamin D and health in adults in Australia and New Zealand: a position statement. Medical Journal of Australia, 196: 686–7.
Rey-Sanchez, P, Lavado-Garcia, JM, Canal-Macias, ML, et al. (2009) Ultrasound bone mass in schizophrenic patients on antipsychotic therapy. Human Psychopharmacology, 24: 4954.
Ross, AC, Manson, JE, Abrams, SA, et al. (2011) The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. Journal of Clinical Endocrinology and Metabolism, 96: 53–8.
Saha, S, Chant, DC, Welham, JL, et al. (2006) The incidence and prevalence of schizophrenia varies with latitude. Acta Psychiatrica Scandinavica, 114: 36–9.
Scientific Advisory Committee on Nutrition. Vitamin D and Health. SACN, 2016 (https://www.gov.uk/government/publications/sacn-vitamin-d-and-health-report).
Sepehrmanesh, Z, Kolahdooz, F, Abedi, F, et al. (2016) Vitamin D supplementation affects the Beck Depression Inventory, insulin resistance, and biomarkers of oxidative stress in patients with major depressive disorder: a randomized, controlled clinical trial. Journal of Nutrition, 146: 243–8.
Stubbs, B, de Hert, M, Sepehry, AA, et al. (2014) A meta-analysis of prevalence estimates and moderators of low bone mass in people with schizophrenia. Acta Psychiatrica Scandinavica, 130: 470–86.
Suetani, S, Saha, S, Eyles, DW, et al. (2017) Prevalence and correlates of suboptimal vitamin D status in people living with psychotic disorders: data from the Australian Survey of High Impact Psychosis. Australian and New Zealand Journal of Psychiatry, 9: 921–9.
Sullivan, EM, O'Donnell, P (2012) Inhibitory interneurons, oxidative stress, and schizophrenia. Schizophrenia Bulletin, 38: 373–6.
Toffanello, ED, Sergi, G, Veronese, N, et al. (2014) Serum 25-hydroxyvitamin d and the onset of late-life depressive mood in older men and women: the Pro.V.A. study. Journals of Gerontology. Series A, 69: 1554–61.
Vieth, R, Kimball, S, Hu, A, et al. (2004) Randomized comparison of the effects of the vitamin D3 adequate intake versus 100 mcg (4000 IU) per day on biochemical responses and the wellbeing of patients. Nutrition Journal, 3: 8.
Wang, TJ, Pencina, MJ, Booth, SL, et al. (2008) Vitamin D deficiency and risk of cardiovascular disease. Circulation, 117: 503–11.
Wang, Y, Liu, Y, Lian, Y, et al. (2016) Efficacy of high-dose supplementation with oral vitamin D3 on depressive symptoms in dialysis patients with vitamin D3 insufficiency: a prospective, randomized, double-blind study. Journal of Clinical Psychopharmacology, 36: 229–35.
Wortsman, J, Matsuoka, LY, Chen, TC, et al. (2000) Decreased bioavailability of vitamin D in obesity. American Journal of Clinical Nutrition, 72: 690–3.
Wrzosek, M, Łukaszkiewicz, J, Wrzosek, M, et al. (2013) Vitamin D and the central nervous system. Pharmacological Reports, 65: 271–8.
Yalamanchili, V, Gallagher, JC (2012) Treatment with hormone therapy and calcitriol did not affect depression in older postmenopausal women: no interaction with estrogen and vitamin D receptor genotype polymorphisms. Menopause, 19: 697703.
Yuksel, RN, Altunsoy, N, Tikir, B, et al. (2014) Correlation between total vitamin D levels and psychotic psychopathology in patients with schizophrenia: therapeutic implications for add-on vitamin D augmentation. Therapeutic Advances in Psychopharmacology, 4: 268–75.
Zanetidou, S, Belvederi Murri, M, Buffa, A, et al. (2011) Vitamin D supplements in geriatric major depression. International Journal of Geriatric Psychiatry, 26: 1209–10.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

BJPsych Advances
  • ISSN: 2056-4678
  • EISSN: 2056-4686
  • URL: /core/journals/bjpsych-advances
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

Vitamin D in schizophrenia and depression: a clinical review

  • John Lally (a1) and Fiona Gaughran (a2)
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *